Alzai Health Partners with Centauri for Alzheimer's AI Solutions
Alzai Health Corp. partners with Centauri to utilize AI solutions for Alzheimer’s early detection, advancing preventive healthcare and value-based care.
Alzheimer's Blood Tests: The Need for Medicare Coverage Reform
Explore the urgent need for Medicare to cover Alzheimer's blood tests to aid early detection and improve patient outcomes—crucial for healthcare reform.
Medicare Cognitive Screening: Early Detection and Coding Compliance Guide
Explore Medicare cognitive screening during Annual Wellness Visits, early detection of cognitive impairment, and compliant ICD-10 coding (G31.84) to ensure accurate documentation and billing practices.
FDA Approves First Blood Test to Aid Alzheimer’s Diagnosis
The FDA has approved Lumipulse, the first blood test for Alzheimer's diagnosis in symptomatic older adults, enabling less invasive detection of amyloid plaques and supporting earlier, accurate diagnosis and treatment options.